Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Major Manufacturers Covered in This Report 1.3 Market Segment by Type 1.3.1 Global Hepatic Encephalopathy (HE) Therapeutics Market Size Growth Rate by Type (2019-2025) 1.3.2 Lactulose 1.3.3 Rifaximin 1.3.4 Neomycin 1.3.5 Probiotics 1.3.6 Thiamine 1.4 Market Segment by Application 1.4.1 Global Hepatic Encephalopathy (HE) Therapeutics Market Share by Application (2019-2025) 1.4.2 Acute Liver Failure 1.4.3 Portal Systemic Bypass Without Liver Disease 1.4.4 Liver Cirrhosis 1.5 Study Objectives 1.6 Years Considered 2 Global Growth Trends 2.1 Global Hepatic Encephalopathy (HE) Therapeutics Market Size 2.1.1 Global Hepatic Encephalopathy (HE) Therapeutics Revenue 2014-2025 2.1.2 Global Hepatic Encephalopathy (HE) Therapeutics Sales 2014-2025 2.2 Hepatic Encephalopathy (HE) Therapeutics Growth Rate by Regions 2.2.1 Global Hepatic Encephalopathy (HE) Therapeutics Sales by Regions 2014-2019 2.2.2 Global Hepatic Encephalopathy (HE) Therapeutics Revenue by Regions 2014-2019 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 3 Market Share by Manufacturers 3.1 Hepatic Encephalopathy (HE) Therapeutics Sales by Manufacturers 3.1.1 Hepatic Encephalopathy (HE) Therapeutics Sales by Manufacturers 2014-2019 3.1.2 Hepatic Encephalopathy (HE) Therapeutics Sales Market Share by Manufacturers 2014-2019 3.2 Revenue by Manufacturers 3.2.1 Hepatic Encephalopathy (HE) Therapeutics Revenue by Manufacturers (2014-2019) 3.2.2 Hepatic Encephalopathy (HE) Therapeutics Revenue Share by Manufacturers (2014-2019) 3.2.3 Global Hepatic Encephalopathy (HE) Therapeutics Market Concentration Ratio (CR5 and HHI) 3.3 Hepatic Encephalopathy (HE) Therapeutics Price by Manufacturers 3.4 Key Manufacturers Hepatic Encephalopathy (HE) Therapeutics Plants/Factories Distribution and Area Served 3.5 Date of Key Manufacturers Enter into Hepatic Encephalopathy (HE) Therapeutics Market 3.6 Key Manufacturers Hepatic Encephalopathy (HE) Therapeutics Product Offered 3.7 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Sales and Revenue for Each Type 4.1.1 Lactulose Sales and Revenue (2014-2019) 4.1.2 Rifaximin Sales and Revenue (2014-2019) 4.1.3 Neomycin Sales and Revenue (2014-2019) 4.1.4 Probiotics Sales and Revenue (2014-2019) 4.1.5 Thiamine Sales and Revenue (2014-2019) 4.2 Global Hepatic Encephalopathy (HE) Therapeutics Sales Market Share by Type 4.3 Global Hepatic Encephalopathy (HE) Therapeutics Revenue Market Share by Type 4.4 Hepatic Encephalopathy (HE) Therapeutics Price by Type 5 Market Size by Application 5.1 Overview 5.2 Global Hepatic Encephalopathy (HE) Therapeutics Sales by Application 6 United States 6.1 United States Hepatic Encephalopathy (HE) Therapeutics Breakdown Data by Company 6.2 United States Hepatic Encephalopathy (HE) Therapeutics Breakdown Data by Type 6.3 United States Hepatic Encephalopathy (HE) Therapeutics Breakdown Data by Application 7 European Union 7.1 European Union Hepatic Encephalopathy (HE) Therapeutics Breakdown Data by Company 7.2 European Union Hepatic Encephalopathy (HE) Therapeutics Breakdown Data by Type 7.3 European Union Hepatic Encephalopathy (HE) Therapeutics Breakdown Data by Application 8 China 8.1 China Hepatic Encephalopathy (HE) Therapeutics Breakdown Data by Company 8.2 China Hepatic Encephalopathy (HE) Therapeutics Breakdown Data by Type 8.3 China Hepatic Encephalopathy (HE) Therapeutics Breakdown Data by Application 9 Rest of World 9.1 Rest of World Hepatic Encephalopathy (HE) Therapeutics Breakdown Data by Company 9.2 Rest of World Hepatic Encephalopathy (HE) Therapeutics Breakdown Data by Type 9.3 Rest of World Hepatic Encephalopathy (HE) Therapeutics Breakdown Data by Application 9.4 Rest of World Hepatic Encephalopathy (HE) Therapeutics Breakdown Data by Countries 9.4.1 Rest of World Hepatic Encephalopathy (HE) Therapeutics Sales by Countries 9.4.2 Rest of World Hepatic Encephalopathy (HE) Therapeutics Revenue by Countries 9.4.3 Japan 9.4.4 Korea 9.4.5 India 9.4.6 Southeast Asia 10 Company Profiles 10.1 ASKA Pharmaceutical 10.1.1 ASKA Pharmaceutical Company Details 10.1.2 Company Description and Business Overview 10.1.3 Sales, Revenue and Market Share of Hepatic Encephalopathy (HE) Therapeutics 10.1.4 Hepatic Encephalopathy (HE) Therapeutics Product Introduction 10.1.5 ASKA Pharmaceutical Recent Development 10.2 COSMO PHARMACEUTICALS 10.2.1 COSMO PHARMACEUTICALS Company Details 10.2.2 Company Description and Business Overview 10.2.3 Sales, Revenue and Market Share of Hepatic Encephalopathy (HE) Therapeutics 10.2.4 Hepatic Encephalopathy (HE) Therapeutics Product Introduction 10.2.5 COSMO PHARMACEUTICALS Recent Development 10.3 Mallinckrodt 10.3.1 Mallinckrodt Company Details 10.3.2 Company Description and Business Overview 10.3.3 Sales, Revenue and Market Share of Hepatic Encephalopathy (HE) Therapeutics 10.3.4 Hepatic Encephalopathy (HE) Therapeutics Product Introduction 10.3.5 Mallinckrodt Recent Development 10.4 Valeant 10.4.1 Valeant Company Details 10.4.2 Company Description and Business Overview 10.4.3 Sales, Revenue and Market Share of Hepatic Encephalopathy (HE) Therapeutics 10.4.4 Hepatic Encephalopathy (HE) Therapeutics Product Introduction 10.4.5 Valeant Recent Development 11 Value Chain and Sales Channels Analysis 11.1 Value Chain Analysis 11.2 Sales Channels Analysis 11.2.1 Hepatic Encephalopathy (HE) Therapeutics Sales Channels 11.2.2 Hepatic Encephalopathy (HE) Therapeutics Distributors 11.3 Hepatic Encephalopathy (HE) Therapeutics Customers 12 Market Forecast 12.1 Global Hepatic Encephalopathy (HE) Therapeutics Sales and Revenue Forecast 2019-2025 12.2 Global Hepatic Encephalopathy (HE) Therapeutics Sales Forecast by Type 12.3 Global Hepatic Encephalopathy (HE) Therapeutics Sales Forecast by Application 12.4 Hepatic Encephalopathy (HE) Therapeutics Forecast by Regions 12.4.1 Global Hepatic Encephalopathy (HE) Therapeutics Sales Forecast by Regions 2019-2025 12.4.2 Global Hepatic Encephalopathy (HE) Therapeutics Revenue Forecast by Regions 2019-2025 12.5 United States Market Forecast 12.6 European Union Market Forecast 12.7 China Market Forecast 12.8 Rest of World 12.8.1 Japan 12.8.2 Korea 12.8.3 India 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.1.1 Research Programs/Design 14.1.1.2 Market Size Estimation 14.1.1.3 Market Breakdown and Data Triangulation 14.1.2 Data Source 14.1.2.1 Secondary Sources 14.1.2.2 Primary Sources 14.2 Author Details 14.3 Disclaimer

List of Tables and Figures Figure Hepatic Encephalopathy (HE) Therapeutics Product Picture Table Hepatic Encephalopathy (HE) Therapeutics Key Market Segments Table Major Manufacturers Hepatic Encephalopathy (HE) Therapeutics Covered in This Report Table Global Hepatic Encephalopathy (HE) Therapeutics Market Size Growth Rate by Type 2019-2025 (K MT) & (Million US$) Figure Global Hepatic Encephalopathy (HE) Therapeutics Sales Market Shar by Type 2014-2025 Figure Lactulose Figures Table Major Manufacturers of Lactulose Figure Rifaximin Figures Table Major Manufacturers of Rifaximin Figure Neomycin Figures Table Major Manufacturers of Neomycin Figure Probiotics Figures Table Major Manufacturers of Probiotics Figure Thiamine Figures Table Major Manufacturers of Thiamine Table Global Hepatic Encephalopathy (HE) Therapeutics Market Share by Application 2019-2025 (K MT) Figure Acute Liver Failure Use Case Figure Portal Systemic Bypass Without Liver Disease Use Case Figure Liver Cirrhosis Use Case Figure Hepatic Encephalopathy (HE) Therapeutics Report Years Considered Figure Global Hepatic Encephalopathy (HE) Therapeutics Market Size 2014-2025 (Million US$) Figure Global Hepatic Encephalopathy (HE) Therapeutics Sales 2014-2019 (K MT) Table Global Hepatic Encephalopathy (HE) Therapeutics Market Size by Regions 2014-2019 (K MT) & (Million US$) Table Global Hepatic Encephalopathy (HE) Therapeutics Sales by Regions 2014-2019 (K MT) Table Global Hepatic Encephalopathy (HE) Therapeutics Sales Market Share by Regions 2014-2019 Figure Global Hepatic Encephalopathy (HE) Therapeutics Sales Market Share by Regions 2014-2019 Figure Global Hepatic Encephalopathy (HE) Therapeutics Sales Market Share by Regions in 2019 Table Global Hepatic Encephalopathy (HE) Therapeutics Revenue by Regions 2014-2019 (Million US$) Table Global Hepatic Encephalopathy (HE) Therapeutics Revenue Market Share by Regions 2014-2019 Figure Global Hepatic Encephalopathy (HE) Therapeutics Revenue Market Share by Regions 2014-2019 Figure Global Hepatic Encephalopathy (HE) Therapeutics Revenue Market Share by Regions in 2019 Table Market Top Trends Table Global Hepatic Encephalopathy (HE) Therapeutics Sales by Manufacturers (2014-2019) (K MT) Table Global Hepatic Encephalopathy (HE) Therapeutics Sales Share by Manufacturers (2014-2019) Figure Global Hepatic Encephalopathy (HE) Therapeutics Sales Share by Manufacturers in 2019 Table Hepatic Encephalopathy (HE) Therapeutics Revenue by Manufacturers (2014-2019) (Million USD) Table Hepatic Encephalopathy (HE) Therapeutics Revenue Share by Manufacturers (2014-2019) Figure Hepatic Encephalopathy (HE) Therapeutics Value Share by Manufacturers in 2019 Table Global Hepatic Encephalopathy (HE) Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Manufacturers Hepatic Encephalopathy (HE) Therapeutics Price (2014-2019) (USD/MT) Table Key Manufacturers Hepatic Encephalopathy (HE) Therapeutics Plants/Factories Distribution Table Key Manufacturers Hepatic Encephalopathy (HE) Therapeutics Area Served Table Date of Key Manufacturers Enter into Hepatic Encephalopathy (HE) Therapeutics Market Table Key Manufacturers Hepatic Encephalopathy (HE) Therapeutics Product Type Table Mergers & Acquisitions, Expansion Plans Table Global Lactulose Sales and Revenue (2014-2019) (K MT) & (Million US$) Table Global Rifaximin Sales and Revenue (2014-2019) (K MT) & (Million US$) Table Global Neomycin Sales and Revenue (2014-2019) (K MT) & (Million US$) Table Global Probiotics Sales and Revenue (2014-2019) (K MT) & (Million US$) Table Global Thiamine Sales and Revenue (2014-2019) (K MT) & (Million US$) Table Global Hepatic Encephalopathy (HE) Therapeutics Sales by Type (2014-2019) (K MT) Table Global Hepatic Encephalopathy (HE) Therapeutics Sales Share by Type (2014-2019) Figure Global Hepatic Encephalopathy (HE) Therapeutics Sales Market Share by Type (2014-2019) Figure Global Hepatic Encephalopathy (HE) Therapeutics Sales Market Share by Type in 2018 Table Global Hepatic Encephalopathy (HE) Therapeutics Revenue by Type (2014-2019) (Million US$) Table Global Hepatic Encephalopathy (HE) Therapeutics Revenue Share by Type (2014-2019) Figure Global Hepatic Encephalopathy (HE) Therapeutics Revenue Market Share by Type (2014-2019) Figure Global Hepatic Encephalopathy (HE) Therapeutics Revenue Market Share by Type in 2018 Table Hepatic Encephalopathy (HE) Therapeutics Price by Type 2014-2019 (USD/MT) Table Global Hepatic Encephalopathy (HE) Therapeutics Sales by Application (2014-2019) (K MT) Table Global Hepatic Encephalopathy (HE) Therapeutics Sales Share by Application (2014-2019) Figure Global Sales Hepatic Encephalopathy (HE) Therapeutics Market Share by Application (2014-2019) Figure Global Sales Hepatic Encephalopathy (HE) Therapeutics Market Share by Application (2014-2019) Figure United States Hepatic Encephalopathy (HE) Therapeutics Sales Growth Rate 2014-2019 (K MT) Figure United States Hepatic Encephalopathy (HE) Therapeutics Revenue Growth Rate 2014-2019 (Million US$) Table United States Hepatic Encephalopathy (HE) Therapeutics Sales by Company (2014-2019) (K MT) Table United States Hepatic Encephalopathy (HE) Therapeutics Sales Market Share by Company (2014-2019) Figure United States Hepatic Encephalopathy (HE) Therapeutics Sales Market Share by Company in 2019 Table United States Hepatic Encephalopathy (HE) Therapeutics Sales by Type (2014-2019) (K MT) Table United States Hepatic Encephalopathy (HE) Therapeutics Sales Market Share by Type (2014-2019) Figure United States Hepatic Encephalopathy (HE) Therapeutics Market Share by Type in 2019 Table United States Hepatic Encephalopathy (HE) Therapeutics Sales by Application (2014-2019) (K MT) Table United States Hepatic Encephalopathy (HE) Therapeutics Sales Market Share by Application (2014-2019) Figure United States Hepatic Encephalopathy (HE) Therapeutics Market Share by Application in 2019 Figure European Union Hepatic Encephalopathy (HE) Therapeutics Sales Growth Rate 2014-2019 (K MT) Figure European Union Hepatic Encephalopathy (HE) Therapeutics Revenue Growth Rate 2014-2019 (Million US$) Table European Union Hepatic Encephalopathy (HE) Therapeutics Sales by Company (2014-2019) (K MT) Table European Union Hepatic Encephalopathy (HE) Therapeutics Sales Market Share by Company (2014-2019) Figure European Union Hepatic Encephalopathy (HE) Therapeutics Sales Market Share by Company in 2019 Table European Union Hepatic Encephalopathy (HE) Therapeutics Sales by Type (2014-2019) (K MT) Table European Union Hepatic Encephalopathy (HE) Therapeutics Sales Market Share by Type (2014-2019) Figure 2018 European Union Hepatic Encephalopathy (HE) Therapeutics Market Share by Type Table European Union Hepatic Encephalopathy (HE) Therapeutics Sales by Application (2014-2019) (K MT) Table European Union Hepatic Encephalopathy (HE) Therapeutics Sales Market Share by Application (2014-2019) Figure 2018 European Union Hepatic Encephalopathy (HE) Therapeutics Market Share by Application Figure China Hepatic Encephalopathy (HE) Therapeutics Sales Growth Rate 2014-2019 (K MT) Figure China Hepatic Encephalopathy (HE) Therapeutics Revenue Growth Rate 2014-2019 (Million US$) Table China Hepatic Encephalopathy (HE) Therapeutics Sales by Company (2014-2019) (K MT) Table China Hepatic Encephalopathy (HE) Therapeutics Sales Market Share by Company (2014-2019) Figure China Hepatic Encephalopathy (HE) Therapeutics Sales Market Share by Company in 2019 Table China Hepatic Encephalopathy (HE) Therapeutics Sales by Type (2014-2019) (K MT) Table China Hepatic Encephalopathy (HE) Therapeutics Sales Market Share by Type (2014-2019) Figure China Hepatic Encephalopathy (HE) Therapeutics Market Share by Type in 2019 Table China Hepatic Encephalopathy (HE) Therapeutics Sales by Application (2014-2019) (K MT) Table China Hepatic Encephalopathy (HE) Therapeutics Sales Market Share by Application (2014-2019) Figure China Hepatic Encephalopathy (HE) Therapeutics Market Share by Application in 2019 Figure Rest of World Hepatic Encephalopathy (HE) Therapeutics Sales Growth Rate 2014-2019 (K MT) Figure Rest of World Hepatic Encephalopathy (HE) Therapeutics Revenue Growth Rate 2014-2019 (Million US$) Table Rest of World Hepatic Encephalopathy (HE) Therapeutics Sales by Company (2014-2019) (K MT) Table Rest of World Hepatic Encephalopathy (HE) Therapeutics Sales Market Share by Company (2014-2019) Figure Rest of World Hepatic Encephalopathy (HE) Therapeutics Sales Market Share by Company in 2019 Table Rest of World Hepatic Encephalopathy (HE) Therapeutics Sales by Type (2014-2019) (K MT) Table Rest of World Hepatic Encephalopathy (HE) Therapeutics Sales Market Share by Type (2014-2019) Figure Rest of World Hepatic Encephalopathy (HE) Therapeutics Market Share by Type in 2019 Table Rest of World Hepatic Encephalopathy (HE) Therapeutics Sales by Application (2014-2019) (K MT) Table Rest of World Hepatic Encephalopathy (HE) Therapeutics Sales Market Share by Application (2014-2019) Figure Rest of World Hepatic Encephalopathy (HE) Therapeutics Market Share by Application in 2019 Table Rest of World Hepatic Encephalopathy (HE) Therapeutics Sales by Countries (2014-2019) (K MT) Table Rest of World Hepatic Encephalopathy (HE) Therapeutics Sales Market Share by Countries (2014-2019) Figure Rest of World Hepatic Encephalopathy (HE) Therapeutics Sales Market Share by Countries in 2019 Table Rest of World Hepatic Encephalopathy (HE) Therapeutics Revenue by Countries (2014-2019) (Million US$) Table Rest of World Hepatic Encephalopathy (HE) Therapeutics Revenue Market Share by Countries (2014-2019) Figure Rest of World Hepatic Encephalopathy (HE) Therapeutics Revenue Market Share by Countries in 2019 Figure Japan Hepatic Encephalopathy (HE) Therapeutics Sales Growth Rate (2014-2019) (K MT) Figure Japan Hepatic Encephalopathy (HE) Therapeutics Revenue Growth Rate (2014-2019) (K MT) Figure Korea Hepatic Encephalopathy (HE) Therapeutics Sales Growth Rate (2014-2019) (K MT) Figure Korea Hepatic Encephalopathy (HE) Therapeutics Revenue Growth Rate (2014-2019) (K MT) Figure India Hepatic Encephalopathy (HE) Therapeutics Sales Growth Rate (2014-2019) (K MT) Figure India Hepatic Encephalopathy (HE) Therapeutics Revenue Growth Rate (2014-2019) (K MT) Figure Southeast Asia Hepatic Encephalopathy (HE) Therapeutics Sales Growth Rate (2014-2019) (K MT) Figure Southeast Asia Hepatic Encephalopathy (HE) Therapeutics Revenue Growth Rate (2014-2019) (K MT) Table ASKA Pharmaceutical Company Details Table ASKA Pharmaceutical Description and Business Overview Table ASKA Pharmaceutical Hepatic Encephalopathy (HE) Therapeutics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019) Table ASKA Pharmaceutical Hepatic Encephalopathy (HE) Therapeutics Sales Growth Rate (2014-2019) Table ASKA Pharmaceutical Hepatic Encephalopathy (HE) Therapeutics Sales Market Share in Global Market Table ASKA Pharmaceutical Recent Development Table COSMO PHARMACEUTICALS Company Details Table COSMO PHARMACEUTICALS Description and Business Overview Table COSMO PHARMACEUTICALS Hepatic Encephalopathy (HE) Therapeutics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019) Table COSMO PHARMACEUTICALS Hepatic Encephalopathy (HE) Therapeutics Sales Growth Rate (2014-2019) Table COSMO PHARMACEUTICALS Hepatic Encephalopathy (HE) Therapeutics Sales Market Share in Global Market Table COSMO PHARMACEUTICALS Recent Development Table Mallinckrodt Company Details Table Mallinckrodt Description and Business Overview Table Mallinckrodt Hepatic Encephalopathy (HE) Therapeutics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019) Table Mallinckrodt Hepatic Encephalopathy (HE) Therapeutics Sales Growth Rate (2014-2019) Table Mallinckrodt Hepatic Encephalopathy (HE) Therapeutics Sales Market Share in Global Market Table Mallinckrodt Recent Development Table Valeant Company Details Table Valeant Description and Business Overview Table Valeant Hepatic Encephalopathy (HE) Therapeutics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019) Table Valeant Hepatic Encephalopathy (HE) Therapeutics Sales Growth Rate (2014-2019) Table Valeant Hepatic Encephalopathy (HE) Therapeutics Sales Market Share in Global Market Table Valeant Recent Development Figure Hepatic Encephalopathy (HE) Therapeutics Value Chain Table Hepatic Encephalopathy (HE) Therapeutics Distributors List Table Hepatic Encephalopathy (HE) Therapeutics Customers List Table Global Hepatic Encephalopathy (HE) Therapeutics Sales Forecast 2019-2025 (K MT) & (Million US$) Figure Global Hepatic Encephalopathy (HE) Therapeutics Sales Forecast 2019-2025 (K MT) Figure Global Hepatic Encephalopathy (HE) Therapeutics Revenue Forecast 2019-2025 (Million US$) Table Global Hepatic Encephalopathy (HE) Therapeutics Sales Forecast by Type 2019-2025 (K MT) Figure Global Hepatic Encephalopathy (HE) Therapeutics Sales Forecast by Type 2019-2025 (K MT) Figure Global Hepatic Encephalopathy (HE) Therapeutics Sales Market Share Forecast by Type 2019-2025 Table Global Hepatic Encephalopathy (HE) Therapeutics Sales Forecast by Application 2019-2025 (K MT) Figure Global Hepatic Encephalopathy (HE) Therapeutics Sales Forecast by Application 2019-2025 (K MT) Figure Global Hepatic Encephalopathy (HE) Therapeutics Sales Market Share Forecast by Application 2019-2025 Table Global Hepatic Encephalopathy (HE) Therapeutics Sales Forecast by Regions 2019-2025 (K MT) Figure Global Hepatic Encephalopathy (HE) Therapeutics Sales Forecast by Regions 2019-2025 (K MT) Figure Global Hepatic Encephalopathy (HE) Therapeutics Sales Market Share Forecast by Regions 2019-2025 Table Global Hepatic Encephalopathy (HE) Therapeutics Revenue Forecast by Regions 2019-2025 (K MT) Figure Global Hepatic Encephalopathy (HE) Therapeutics Revenue Forecast by Regions 2019-2025 (K MT) Figure Global Hepatic Encephalopathy (HE) Therapeutics Revenue Market Share Forecast by Regions 2019-2025 Figure United States Hepatic Encephalopathy (HE) Therapeutics Sales Forecast 2019-2025 (K MT) Figure United States Hepatic Encephalopathy (HE) Therapeutics Revenue Forecast 2019-2025 (Million US$) Figure European Union Hepatic Encephalopathy (HE) Therapeutics Sales Forecast 2019-2025 (K MT) Figure European Union Hepatic Encephalopathy (HE) Therapeutics Revenue Forecast 2019-2025 (Million US$) Figure China Hepatic Encephalopathy (HE) Therapeutics Sales Forecast 2019-2025 (K MT) Figure China Hepatic Encephalopathy (HE) Therapeutics Revenue Forecast 2019-2025 (Million US$) Figure Japan Hepatic Encephalopathy (HE) Therapeutics Sales Forecast 2019-2025 (K MT) Figure Japan Hepatic Encephalopathy (HE) Therapeutics Revenue Forecast 2019-2025 (Million US$) Figure Korea Hepatic Encephalopathy (HE) Therapeutics Sales Forecast 2019-2025 (K MT) Figure Korea Hepatic Encephalopathy (HE) Therapeutics Revenue Forecast 2019-2025 (Million US$) Figure India Hepatic Encephalopathy (HE) Therapeutics Sales Forecast 2019-2025 (K MT) Figure India Hepatic Encephalopathy (HE) Therapeutics Revenue Forecast 2019-2025 (Million US$) Figure Southeast Asia Hepatic Encephalopathy (HE) Therapeutics Sales Forecast 2019-2025 (K MT) Figure Southeast Asia Hepatic Encephalopathy (HE) Therapeutics Revenue Forecast 2019-2025 (Million US$) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

ASKA Pharmaceutical COSMO PHARMACEUTICALS Mallinckrodt Valeant